| SARS-CoV-2 viral load is associated with increased disease severity and mortality J Fajnzylber, J Regan, K Coxen, H Corry, C Wong, A Rosenthal, D Worrall, ... Nature communications 11 (1), 5493, 2020 | 912 | 2020 |
| Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19 N Kaneko, HH Kuo, J Boucau, JR Farmer, H Allard-Chamard, ... Cell 183 (1), 143-157. e13, 2020 | 741 | 2020 |
| Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity E Shrock, E Fujimura, T Kula, RT Timms, IH Lee, Y Leng, ML Robinson, ... Science 370 (6520), eabd4250, 2020 | 631 | 2020 |
| Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2 JM Francis, D Leistritz-Edwards, A Dunn, C Tarr, J Lehman, C Dempsey, ... Science immunology 7 (67), eabk3070, 2021 | 88 | 2021 |
| Phenotypic signatures of immune selection in HIV-1 reservoir cells W Sun, C Gao, CA Hartana, MR Osborn, KB Einkauf, X Lian, B Bone, ... Nature 614 (7947), 309-317, 2023 | 82 | 2023 |
| Urinary bladder cancer tregs suppress MMP2 and potentially regulate invasiveness ME Winerdal, D Krantz, CA Hartana, AA Zirakzadeh, L Linton, ... Cancer immunology research 6 (5), 528-538, 2018 | 63 | 2018 |
| Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer CA Hartana, E Ahlén Bergman, A Broomé, S Berglund, M Johansson, ... Clinical & Experimental Immunology 194 (1), 39-53, 2018 | 53 | 2018 |
| Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection NJ Silverstein, Y Wang, Z Manickas-Hill, C Carbone, A Dauphin, ... Elife 11, e74681, 2022 | 45 | 2022 |
| Massachusetts Consortium on Pathogen Readiness Specimen Working Group Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19 N Kaneko, HH Kuo, J Boucau, JR Farmer, H Allard-Chamard, ... Cell 183 (1), 143-157, 2020 | 42 | 2020 |
| Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer AA Zirakzadeh, J Kinn, D Krantz, R Rosenblatt, ME Winerdal, J Hu, ... Clinical immunology 176, 63-70, 2017 | 39 | 2017 |
| Facing the future: challenges and opportunities in adoptive T cell therapy in cancer I Magalhaes, C Carvalho-Queiroz, CA Hartana, A Kaiser, A Lukic, M Mints, ... Expert opinion on biological therapy 19 (8), 811-827, 2019 | 37 | 2019 |
| Long noncoding RNA MIR4435-2HG enhances metabolic function of myeloid dendritic cells from HIV-1 elite controllers CA Hartana, Y Rassadkina, C Gao, E Martin-Gayo, BD Walker, ... The Journal of Clinical Investigation 131 (9), 2021 | 35 | 2021 |
| Neoadjuvant chemotherapy reinforces antitumour T cell response in urothelial urinary bladder cancer D Krantz, CA Hartana, ME Winerdal, M Johansson, F Alamdari, ... European urology 74 (6), 688-692, 2018 | 35 | 2018 |
| Immunological effector mechanisms in HIV-1 elite controllers CA Hartana, GY Xu Current opinion in HIV and AIDS 16 (5), 243-248, 2021 | 31 | 2021 |
| Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours CA Hartana, J Kinn, R Rosenblatt, S Anania, F Alamdari, H Glise, A Sherif, ... British journal of cancer 115 (8), 957-966, 2016 | 30 | 2016 |
| Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients E Ahlén Bergman, CA Hartana, M Johansson, LB Linton, S Berglund, ... Clinical Epigenetics 10, 1-15, 2018 | 26 | 2018 |
| Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathway CA Hartana, E Ahlén Bergman, AA Zirakzadeh, D Krantz, ME Winerdal, ... PLoS One 13 (7), e0200079, 2018 | 25 | 2018 |
| Immune correlates of HIV-1 reservoir cell decline in early-treated infants CA Hartana, P Garcia-Broncano, Y Rassadkina, X Lian, C Jiang, ... Cell Reports 40 (3), 2022 | 24 | 2022 |
| Viral load kinetics of severe acute respiratory syndrome coronavirus 2 in hospitalized individuals with coronavirus disease 2019 J Regan, JP Flynn, A Rosenthal, H Jordan, Y Li, R Chishti, F Giguel, ... Open Forum Infectious Diseases 8 (8), ofab153, 2021 | 21 | 2021 |
| Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a M Armani-Tourret, C Gao, CA Hartana, WW Sun, L Carrere, L Vela, ... Cell 187 (5), 1238-1254. e14, 2024 | 7 | 2024 |
